These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15712839)

  • 1. [Acute development of flatfoot in connection with fluoroquinolone therapy].
    Harve H; Michelsson O; Hoikka V; Koskinen SK; Harilainen A
    Duodecim; 2005; 121(1):79-83. PubMed ID: 15712839
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoroquinolone-induced acute interstitial nephritis in immunocompromised patients: two case reports.
    Hung CC; Kuo MC; Chang JM; Chen HC
    Nephrol Dial Transplant; 2006 Jan; 21(1):237-8. PubMed ID: 16204275
    [No Abstract]   [Full Text] [Related]  

  • 3. [The rupture of both Achilles tendons as a complication from fluoroquinolone treatment].
    Pohjola-Sintonen S; Kannisto M
    Duodecim; 2004; 120(8):975-9. PubMed ID: 15185511
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoroquinolone use is the predominant risk factor for the development of a new strain of clostridium difficile-associated disease.
    Patel NS
    BJU Int; 2007 Jun; 99(6):1333-4. PubMed ID: 17233799
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluoroquinolone-resistant Escherichia coli in the long-term care setting.
    Cohen AE; Lautenbach E; Morales KH; Linkin DR
    Am J Med; 2006 Nov; 119(11):958-63. PubMed ID: 17071164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients.
    Urbánek K; Kolár M; Strojil J; Koukalová D; Cekanová L; Hejnar P
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):741-5. PubMed ID: 15880441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National trends in emergency department antibiotic prescribing for elders with urinary tract infection, 1996-2005.
    Caterino JM; Weed SG; Espinola JA; Camargo CA
    Acad Emerg Med; 2009 Jun; 16(6):500-7. PubMed ID: 19245373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatives to fluoroquinolones.
    Med Lett Drugs Ther; 2016 Jun; 58(1496):75-6. PubMed ID: 27249097
    [No Abstract]   [Full Text] [Related]  

  • 9. Empiric treatment of uncomplicated urinary tract infection with fluoroquinolones in older women in Israel: another lost treatment option?
    Kahan NR; Chinitz DP; Waitman DA; Dushnitzky D; Kahan E; Shapiro M
    Ann Pharmacother; 2006 Dec; 40(12):2223-7. PubMed ID: 17105833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The normal and the pathological foot].
    Doncker E
    Ned Tijdschr Geneeskd; 1971 Dec; 115(50):2136-8. PubMed ID: 5147915
    [No Abstract]   [Full Text] [Related]  

  • 11. Does in vitro fluoroquinolone resistance predict clinical failure in urinary tract infections?
    Miller LG; Mehrotra R; Tang AW
    Int J Antimicrob Agents; 2007 May; 29(5):605-7. PubMed ID: 17293087
    [No Abstract]   [Full Text] [Related]  

  • 12. Patients at Risk for Aortic Rupture Often Exposed to Fluoroquinolones during Hospitalization.
    Frankel WC; Trautner BW; Spiegelman A; Grigoryan L; LeMaire SA
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.
    Gagliotti C; Buttazzi R; Sforza S; Moro ML;
    J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
    Guneysel O; Onur O; Erdede M; Denizbasi A
    J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone antibiotics in infants and children.
    Schaad UB
    Infect Dis Clin North Am; 2005 Sep; 19(3):617-28. PubMed ID: 16102652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
    Iannini PB
    Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current challenges in the treatment of complicated urinary tract infections and prostatitis.
    Wagenlehner FM; Naber KG
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():67-80. PubMed ID: 16669930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified Hoke-Miller flatfoot procedure.
    Duncan JW; Lovell WW
    Clin Orthop Relat Res; 1983 Dec; (181):24-7. PubMed ID: 6641059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary tract infections in cats.
    Litster AL; Moss SM; Trott DJ
    J Small Anim Pract; 2008 Aug; 49(8):426. PubMed ID: 18768075
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluoroquinolones may delay the diagnosis of tuberculosis.
    Ang D; Hsu AA; Tan BH
    Singapore Med J; 2006 Sep; 47(9):747-51. PubMed ID: 16924354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.